The MRF Breakthrough Consortium Young Investigator Team Award to Advance the Field of Translational Immuno-Oncology (MRFBC) funding call from the Melanoma Research Foundation (MRF) supports an investigative team whose research focuses on either improving clinical outcomes for patients with melanoma being treated with immuno‐oncology agents or advancing the scientific understanding of immuno‐oncology and the role of the immune system in melanoma. Teams must involve collaborations from at least two different institutions, one of which must be an MRFBC member institution. Further, the proposed PI and all co-PIs must be junior scientists, all of whom have at least one mentor. Applicants must be based at research institutions in the USA. The Grant provides 150,000 USD/year for 2 years and does not cover institutional indirect costs.
Applications close on July 17, 2023.
